Study vs VIPro
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Study
Read full descriptionHide full description
这是一个由葛兰素史克（上海）医药研发公司（GSK）开发的一款致力于GSK临床试验的应用。它可以方便临床试验中的资料查看，反馈收集以及发送通知
VIPro
Read full descriptionHide full description
Virtual Interactive Protocol (VIPro™) is a technology platform tailored for complex clinical studies, aiming to enhance study performance, efficiency, and compliance. It acts as a digital companion for study protocols and documents, consolidating resources for site staff in one accessible location. VIPro ensures protocol comprehension, improves enrollment speed, and minimizes protocol violations. Developed by Syneos Health, it facilitates real-time updates to protocols and resources, ensuring accuracy and consistency across all sites. With analytics for monitoring user activity and communication tools for staying informed, VIPro enhances study management seamlessly across devices.
Screenshots
Verdict
The clearest difference is ads: VIPro at none against Study's shown. VIPro also leads on update cadence (every 2 days vs every 3 months). On price, in-app purchases, device support and iOS requirement there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Study ships an update every 3 months, VIPro every 2 days. The most recent releases landed on September 19, 2026 and October 2, 2026 respectively.
| Parameter | Study | VIPro |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 3 months | Every 2 days — better |
| Ads | Yes | No — better |
| In-app purchases | No | No |
| Devices | iPhone, iPod | iPhone, iPad, iPod — better |
| Requires iOS | 12.1 | 12.0 — better |
| Further details — not scored | ||
| Size | 46 MB | 15 MB |
| Age rating | 17+ | 17+ |
| Developer | GlaxoSmithKline (Shanghai) Pharmaceutical R&D Co., Ltd. | Cadent powered by Syneos Health |
In-app purchases
Study
No in-app purchases
VIPro
No in-app purchases
